ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA-RELATED CHANGES
Clinical trials for ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA-RELATED CHANGES explained in plain language.
Never miss a new study
Get alerted when new ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA-RELATED CHANGES trials appear
Sign up with your email to follow new studies for ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA-RELATED CHANGES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail shows promise for tough leukemia in younger patients
Disease control OngoingThis study tests a chemotherapy drug called CPX-351 in people under 60 with secondary acute myeloid leukemia (AML), a type of leukemia that develops after other bone marrow diseases or cancer treatments. The goal is to see how many patients achieve complete remission. 21 particip…
Matched conditions: ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA-RELATED CHANGES
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New combo tackles Hard-to-Treat leukemia
Disease control OngoingThis study tests a combination of two drugs, CPX-351 and glasdegib, in adults with a specific type of acute myeloid leukemia (AML) that is either linked to a prior bone marrow disorder or caused by previous cancer treatment. The goal is to see if the combo helps patients stay in …
Matched conditions: ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA-RELATED CHANGES
Phase: PHASE2 • Sponsor: University of California, Irvine • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
New hope for tough leukemia: drug combo shows promise in early trial
Disease control OngoingThis study tests a new drug called pevonedistat alongside standard chemotherapy for people with a high-risk type of acute myeloid leukemia (AML). The goal is to see if the combination is safe and works better at getting the cancer into remission. About 53 adults with newly diagno…
Matched conditions: ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA-RELATED CHANGES
Phase: PHASE1, PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated May 19, 2026 11:46 UTC